D-1263-2014 Class I Terminated

Recalled by Medisca Inc. — Irving, TX

FDA drug recall D-1263-2014 was initiated by Medisca Inc. on Oct 21, 2013 and is designated Class I. Reason for recall: Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label. The recall status is terminated (terminated Nov 16, 2016). Affected quantity: 296 units.

Recall details

Product Type
Drugs
Report Date
May 7, 2014
Initiation Date
Oct 21, 2013
Termination Date
Nov 16, 2016
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
296 units

Product description

Human Chorionic Gonadotropin, EP (HCG) in 5 mu. 2 mu, and 1 mu packages, For use and distribution in prescription compounding, manufacturing, processing or repacking only in accordance with FDA regulations and applicable law. Potency 5489.6IU/mg. Packed by Medisca, Inc. Irving, TX, 75063, USA NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6. Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16, CAS 9002-61-3; and 101799/A, Exp: 05/16, CAS: 9002-61-3

Reason for recall

Labeling: Label Error on Declared Strength; Firm states that erroneous potency information was found on the label.

Distribution pattern

Nationwide

Code information

Lot Numbers 101751/A, Exp: 05/16, CAS: 9002-61-3; 101752/A, Exp: 05/16, CAS 9002-61-3; and 101799/A, Exp: 05/16, CAS: 9002-61-3. NDC 38779-2673-1, NDC 38779-2673-2, and NDC 38779-2673-6.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1263-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1263-2014. Report a data issue: hello@regdatalab.com.